Showing results (3871-3880 of 9,339) with videos related to
Sort By:
Pageof 934
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.Cancer Medicine|April 15, 2016
Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinomaCi Song, Yao Liu, Lu Xu, et al.Cancer Medicine|April 15, 2016
A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsToshihiko Doi, Kyung-Hun Lee, Tae-Min Kim, et al.Cancer Medicine|April 10, 2016
GABAB R/GSK-3β/NF-κB signaling pathway regulates the proliferation of colorectal cancer cellsQing Shu, Jun Liu, Xiupeng Liu, et al.Cancer Medicine|April 11, 2016
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinomaIemasa Koh, Takao Hinoi, Kazuhiro Sentani, et al.Cancer Medicine|April 11, 2016
Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma developmentLinli Zhou, Kun Yang, R Randall Wickett, et al.Cancer Medicine|August 16, 2017
Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched studyYung-Chih Chou, Chien-Yu Lin, Ping-Ching Pai, et al.Cancer Medicine|July 19, 2017
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation statusBenjamin Izar, William Sharfman, F Stephen Hodi, et al.Cancer Medicine|August 3, 2017
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agentBeverly A Teicher, Thomas Silvers, Michael Selby, et al.Cancer Medicine|July 19, 2017
Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologistsFrédéric Illouz, Claire Briet, Lucie Cloix, et al.Pageof 934